Therapeutic Drug Monitoring Assays

Therapeutic Drug Monitoring (TDM) chromatographic kits for HPLC, GC, GC-MS, and LC-MS/MS analytical instruments. Enables quantitative analysis of drug concentrations in patient samples to optimize medication dosing and therapeutic outcomes. Includes calibrators, controls, and screening/confirmation assays for clinical chemistry applications.

Specialized assays for measuring kinase inhibitor drug levels and activity. Supports therapeutic monitoring of targeted cancer therapies.

Diagnostic assays for cancer-related tumor marker detection and measurement. Supports oncology diagnostics and cancer monitoring applications.

Tests for thrombotic thrombocytopenic purpura diagnosis and monitoring. Assists in identification of microangiopathic hemolytic anemia.

Diagnostic tests for measuring therapeutic drug levels and drug metabolite concentrations in patient blood samples. These tests ensure optimal medication dosing and help prevent drug toxicity in clinical populations.

Diagnostic test solutions for multiple sclerosis detection and monitoring. Biomarker-based assays for MS disease assessment and management.

Advanced T-cell diagnostic assays that enable precise analysis of T-cell function and activity for developing tailored therapies for various diseases. These tests utilize proprietary, patented technologies to achieve pathogen-specific stimulation of cell-mediated immune response and subsequent identification of secreted biomarkers. The assays are designed to support personalized medicine approaches by interrogating the immune system.

Immunoassay reagents for quantitative detection of tumor-associated biomarkers. Supports oncology screening and monitoring applications.

Immunoassay-based screening tests for detection of controlled substances in biological samples. These assays are used for workplace and clinical toxicology testing.

Immunoassay tests for detection and quantification of cancer-related tumor markers. Supports oncology screening and monitoring applications in clinical laboratories.

Assays designed to measure blood levels of antipsychotic drugs prescribed for serious mental illnesses such as Schizophrenia and Bipolar Disorders. Utilizing nanoparticle technology, these assays provide data for healthcare professionals to monitor the efficacy of drugs commonly used in the treatment of psychosis, including Clozapine, Risperidone/Paliperidone, Olanzapine, and Aripiprazole. The platform is suitable for both point-of-care settings and traditional analyzers in clinical laboratories.

Assays measuring cellular metabolic activity and toxicological response. Used in drug screening, toxicity testing, and cell-based diagnostic applications.